Literature DB >> 8385433

Purification and catalytic properties of liver alcohol dehydrogenase isoenzymes in patients with hepatoma in Nigeria.

I O Ogunleye1, S O Olusi.   

Abstract

Alcohol dehydrogenase isoenzymes were isolated from the liver of patients with hepatoma and healthy control individuals. Whereas only a single form of the enzyme was obtained in healthy control liver, two distinct forms of the enzyme were found in hepatoma liver. These two forms were named AD-I and AD-II according to their elution pattern in CM-cellulose chromatography and mobility towards the anode in polyacrylamide gel electrophoresis. Both isoenzymes resembled normal liver enzyme with respect to their molecular properties. However, the two forms had distinct kinetic properties, although AD-I had some properties similar to the normal liver enzyme. The Km values of AD-I for ethanol, n-butanol and m-nitrobenzyl alcohol were 61 microM, 90 microM and 292 microM, respectively, as against the values for AD-II which were 473 microM, 100 microM and 60 microM for the respective substrates. Pyrazole inhibited the activity of AD-II but not that of AD-I. These kinetic properties of alcohol dehydrogenase in patients with hepatoma could be of clinical importance particularly in the tropics where the disease is prevalent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385433     DOI: 10.1177/000456329303000206

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  2 in total

1.  Activity of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the sera of patients with breast cancer.

Authors:  Wojciech Jelski; Lech Chrostek; Wlodzimierz Markiewicz; Maciej Szmitkowski
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  The activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in liver cancer.

Authors:  Wojciech Jelski; Bogdan Zalewski; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2008-01-26       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.